A2 Refereed review article in a scientific journal

Developments in preclinical cancer imaging: innovating the discovery of therapeutics




AuthorsConway JR, Carragher NO, Timpson P

Publication year2014

JournalNature Reviews Cancer

Journal name in sourceNature reviews. Cancer

Journal acronymNat Rev Cancer

Volume14

Issue5

First page 314

Last page28

Number of pages15

ISSN1474-175X

eISSN1474-1768

DOIhttps://doi.org/10.1038/nrc3724(external)


Abstract
Integrating biological imaging into early stages of the drug discovery process can provide invaluable readouts of drug activity within complex disease settings, such as cancer. Iterating this approach from initial lead compound identification in vitro to proof-of-principle in vivo analysis represents a key challenge in the drug discovery field. By embracing more complex and informative models in drug discovery, imaging can improve the fidelity and statistical robustness of preclinical cancer studies. In this Review, we highlight how combining advanced imaging with three-dimensional systems and intravital mouse models can provide more informative and disease-relevant platforms for cancer drug discovery.



Last updated on 2024-26-11 at 21:36